SCHEMBL23309480

SCHEMBL23309480

COc1cc(NC(=O)c2cc(F)nc(F)c2F)cc(OC)c1OC

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.53
▸ LMNA P02545 3/20 0.53
▸ HTT P42858 1/20 0.50
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ MAPT P10636 3/20 0.49
▸ TP53 P04637 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ PKM P14618 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ ATM Q13315 1/20 0.46
▸ P4HTM Q9NXG6 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ TOP1 P11387 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309497 0.86 KMT2A (0.57) ALDH1A1LMNAHTTSMN1; SMN2MAPT
SCHEMBL23309477 0.84 ATF1 (0.51) ALDH1A1HTTSMN1; SMN2MAPTTP53
SCHEMBL23309711 0.84 GRM4 (0.53) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL23309617 0.80 NPC1 (0.54) ALDH1A1LMNASMN1; SMN2MAPTTP53
SCHEMBL23309587 0.79 MAPT (0.47) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL23309730 0.78 KMT2A (0.47) ALDH1A1LMNAHTTSMN1; SMN2MAPT
SCHEMBL23309502 0.77 NFKB1 (0.51) ALDH1A1HTTSMN1; SMN2MAPTTP53
SCHEMBL23309621 0.75 RAB9A (0.50) ALDH1A1LMNAHTTSMN1; SMN2MAPT
SCHEMBL23309490 0.75 GAA (0.51) ALDH1A1LMNAHTTSMN1; SMN2TP53
SCHEMBL23309640 0.74 DHODH (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL ALDH1A1 2033/4885LMNA 3312/4885HTT 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback